in eyes with initial visual acuity of 6/12 or better.
Although the pathogenesis, clinical features, and natural history of central serous retinopathy (CSR) have been more clearly defined in recent years, the indications for treatment are not precisely established. While many forms of therapy have been advocated, the benign nature of the condition and its tendency to recover spontaneously make their critical evaluation difficult. The predilection of CSR for young males, its tendency to persist for long periods, and the high recurrence rate make effective treatment desirable.
The ability to demonstrate the source of subretinal fluid in CSR by fluorescein fundus angiography (Maumenee, 1965;  Gass, 1967) , together with development of more sophisticated photocoagulation techniques (Wessing, 1971) , suggested that an effective method of treatment might be available. Recent studies have shown that photocoagulation causes rapid resolution of the serous retinal detachment with symptomatic recovery (Spalter, 1968; Peabody et al., 1968; Watzke et al., 1974; Nanjiani, 1977) .
On the basis of clinical impression it is acknowledged that photocoagulation can be justified if corrected visual acuity is worse than 6/12 (Hogan, 1974) or 0O8 (Wessing, 1974) , if it is a second attack in the eye in question, and if there has been a permanent loss of acuity in the fellow eye from central serous retinopathy (Gass, 1974a) . If the corrected visual acuity is good, some clinicians do not treat the condition (Hogan, 1974; Schoch, 1974; Klein et al., 1974) , while others recommend therapy if there are morphological changes in the detached retina, or if the symptoms interfere significantly with life (Wessing, 1974) , though symptoms may persist after retinal reattachment and may never fully resolve (Gass, 1974b; Zweng, 1974) .
Correspondence to P. K. Leaver, FRCS. In the common situation when these indications are absent it has been suggested that photocoagulation can be justified 2 or 3 months (Amalric, 1974; Gass, 1974a; Nanjiani, 1977) Of the 67 patients entered 4 had to be withdrawn, 3 because of failure to attend for follow-up examination and 1 who developed a disciform lesion. There were 53 males and 10 females, their ages ranging from 25 to 53 years with a mean of 40-1. The period of time between onset and presentation varied from 2 days to 35 weeks, with a mean of 5-6 weeks. Fifty-six of the patients were Caucasians, 9 were Asians and 2 Negroes.
Results
In all 67 eyes serous retinal detachment was associated with a demonstrable leak of fluorescein dye through the retinal pigment epithelium. In 35 patients (49%) transmission defects in the RPE were also found or there was a clear history of similar attacks previously in the same eye. RECOVERY TIME Complete recovery as shown by resolution of symptoms, reattachment of the retina, and absence of dye leakage on FFA, occurred at a mean time of 6-2 weeks from entry into the treated group and 16&0 weeks into the control group (P<0 001).
VISUAL ACUITIES
Snellen acuities were converted to a simple numerical scale from 1 (6/4) to 5 (6/12). The mean acuity on presentation was 4-1 for the control group and 3 9 for the treated group of patients and improved to 3-1 and 2-9 respectively at 6 months (Table 1) .
A significant difference between the visual acuities of the treated and untreated eyes occurred at 2 months after entry but at no other time. The mean visual acuity of the fellow eyes was 2-8 (Table 1 , Fig. 1 ). Nine patients failed to achieve a final acuity of 6/6 or better. Six of these were in the control group and 3 were in the treated group; in all these cases the final acuity was 6/9. In no instance was it necessary to withdraw a patient from the trial because of a fall in visual acuity to less than 6/12.
HUE DISCRIMINATION
At entry the mean of the 100-hue scores in the control group was 212 and in the treated group 282, improving to 137 and 156 respectively at 6 months. No significant difference between the mean scores of the 2 groups was found at any stage (Table 1 ).
The mean 100-hue score of the fellow eyes was 90. (Gass, 1972) .
Finally, some authors have claimed that photocoagulation may precipitate a disciform lesion, with the serious threat to central vision that such a lesion carries (Francois et al., 1975; Schatz et al., 1977) . While in most patients treatment with the argon laser can be safely undertaken, there is a small proportion in whom the proximity of the leaking point to the fovea or to the major blood vessels makes this procedure hazardous, and indirect treatment may not be a practicable alternative to photocoagulation of the leaking site itself.
We conclude from our observations that, while laser photocoagulation is a safe and satisfactory method of treatment in those cases with distressing symptoms, there is no evidence that it influences the final visual outcome in patients whose vision is 6/12 or better and where there is no evidence of structural retinal damage. Treatment can be justified when the visual deficit affects the quality of life, particularly ability to work, but not on the basis of length of detachment alone. It should be possible to make a decision concerning treatment at the onset of the disease, as there is no evidence to suggest that the prognosis is influenced by the duration of serous detachment.
